| Name | Title | Contact Details |
|---|---|---|
Amy Ponpipom |
Senior Counsel | Profile |
Phil Link |
Associate Director Audit and Compliance, Market Access Strategy Pricing and Operations | Profile |
Aliya Seward |
Global Compliance Associate Director, Oncology Business Unit | Profile |
Danelco Moxey |
Legal Director | Profile |
Michelle Dennison Lutz |
Global Legal Director, Respiratory and Immunology | Profile |
ICORE Healthcare is a Orlando, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Pharvaris is a clinical-stage company focused on bringing oral bradykinin-B2-receptor antagonists to patients. By targeting this clinically proven therapeutic target with novel small molecules, the Pharvaris team is advancing new alternatives to injected therapies for all sub-types of HAE and other bradykinin-mediated diseases. The company brings together executives with a breadth of expertise across pharmaceutical development and rare disorders, including HAE. The company reunites the core team responsible for the discovery and approval of the HAE treatment icatibant. With novel small molecules, we have identified and are advancing potent, orally available compounds targeting this clinically proven therapeutic target.
Berg Pharma focuses research on understanding how alterations in metabolism relate to disease onset. The company has a deep pipeline of early-stage technologies in CNS diseases and metabolic diseases that complement its late-stage clinical trial activity in cancer and prevention of chemotoxicity. Armed with use of the Berg Interrogative Biology™ discovery platform that translates biological output into therapeutic candidates, Berg Pharma is well positioned for rapid commercialization of its intellectual capital.
NxStage System One dialysis machines offer the comfort and flexibility of hemodialysis at home. Discover how our products can improve your quality of life.
OmegaChem is a Levis, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.